Therapie

Papers
(The H4-Index of Therapie is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Uses of pharmacovigilance databases: An overview95
“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers87
Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection70
Safety data and withdrawal of hepatotoxic drugs54
Addictovigilance contribution during COVID-19 epidemic and lockdown in France51
Pharmacovigilance and drug safety: Fair prescribing and clinical research49
Polypharmacy: A general review of definitions, descriptions and determinants37
Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations33
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT)33
Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence33
Efficacy of COVID-19 vaccines: From clinical trials to real life30
Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres25
French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge23
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy22
Diabetes and COVID-1921
Prolonged-release buprenorphine formulations: Perspectives for clinical practice20
Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France20
Chloroquine and hydroxychloroquine during pregnancy: What do we know?19
0.047071218490601